Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and...
Transcript of Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and...
![Page 1: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/1.jpg)
Slides current until 2008
Diagnosis, classification and prevention of diabetes
Section 1 | 1 of 4
Curriculum Module II–1 | Diagnosis, classification and presentation of diabetes
![Page 2: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/2.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 2 of 48
Polyurea
![Page 3: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/3.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 3 of 48
Definition of diabetes
Characterized by hyperglycaemia
• Defects in insulin production
• Autoimmune or otherdestruction of beta cells
• Insulin insensitivity
• Impaired action of insulin on target tissues
![Page 4: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/4.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 4 of 48
Definition of diabetes
Chronic hyperglycaemia associatedwith long-term damage to:
• Eyes
• Kidneys
• Nerves
• Heart and blood vessels
![Page 5: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/5.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 5 of 48
The diabetes epidemic
• 230 million affected in 2006
• 350 million within 20 years
• Most rapid in Indian and Asian subcontinents
IDF Diabetes Atlas
![Page 6: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/6.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 6 of 48
Classification
• Type 1 diabetes
– autoimmune
– LADA
– idiopathic
• Type 2 diabetes
![Page 7: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/7.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 7 of 48
Other specific types
• MODY
• Defects in insulin action
• Diseases of the pancreas
• Endocrine disorders
• Drug- or chemical-induced
• Infections
Classification
![Page 8: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/8.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 8 of 48
• Uncommon forms of immune-mediated diabetes
• Other genetic syndromes
• Gestational diabetes
Classification
![Page 9: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/9.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 9 of 48
Insulin
GluconeogenesisGlycogenolysisGlycogen synthesis
Glucose uptakeGlycogen synthesis
Blood glucose
Insulin and glucose disposal
Free fatty acid release
![Page 10: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/10.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 10 of 48
Glucose uptakeGlycogenolysisGluconeogenesis (amino acids)Ketone production (fatty acids)
Glucose uptakeProtein degradation → amino acids
Blood glucose
Insulin deficiency in type 1 diabetes
Triglyceride degradation → fatty acids
![Page 11: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/11.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 11 of 48
![Page 12: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/12.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 12 of 48
Glucose uptake
Glycolysis
Gluconeogenesis (amino acids)
Glucose uptakeProtein degradation → amino acids
Blood glucose
Insulin insensitivity inttype 2 diabetes
![Page 13: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/13.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 13 of 48
![Page 14: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/14.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 14 of 48
![Page 15: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/15.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 15 of 48
Beta-cell mass
Pathogenesis of type 1 diabetes
Time (months - years)
Trigger
Genetic
Pre-diabetes ‘Honeymoon’
Chronic phase
Clinical diabetes
Immunological abnormalities
![Page 16: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/16.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 16 of 48
Idiopathic type 1 diabetes
Non-autoimmune type 1 diabetes
• No autoimmune markers
• Permanent insulinopenia
• Ketoacidosis
• People of African and Asian origin
![Page 17: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/17.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 17 of 48
• Age of onset peaks
–preschool
–puberty
• Autumn/winter peaks
Epidemiology of type 1 diabetes
![Page 18: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/18.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 18 of 48
Type 2 diabetes
• 90%-95% of people withdiabetes
• Insulin insensitivity andrelative insulin deficiency
• Obesity or overweight
• Complications often presentat diagnosis
![Page 19: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/19.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 19 of 48
Pathogenesis of type 2 diabetes
• Multiple genes involved
• Hyperinsulinaemia
• Poor fetal nutrition → ↓ beta-cell formation
• Low birth weight/weight change
• “Thrifty gene”
![Page 20: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/20.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 20 of 48
Age (years)
Endogenous insulin
Insulin requirements
Beta-cell loss
The natural history of type 2 diabetes
↑ Insulin requirements with age
Primary failure
![Page 21: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/21.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 21 of 48
Epidemiology of type 2 diabetes
• Dramatic increase
• Aging population
• Disturbing trends parallel obesity epidemic
• Especially in adolescents and minority groups
• Increasing in young people
![Page 22: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/22.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 22 of 48ACTIVITY
• What are the most common risk factors for type 2 diabetes for people in your country?
• Are any of these risk factors modifiable?
![Page 23: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/23.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 23 of 48
Risk factors for type 2 diabetes
• Age > 40 years
• First-degree relative with diabetes
• Member of high risk population
• History of impaired glucose tolerance, impaired fasting glucose
• Vascular disease
• History of gestational diabetes
• History of delivery of macrosomicbaby
CDA 2003
![Page 24: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/24.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 24 of 48
• Hypertension
• Dyslipidaemia
• Abdominal obesity
• Overweight
• Polycystic ovary disease
• Acanthosis nigricans
• Schizophrenia
Risk factors for type 2 diabetes
![Page 25: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/25.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 25 of 48
• Polydipsia
• Polyuria
• Nocturia
• Visual disturbance
• Fatigue
• Weight loss
• Infections
Signs and symptoms
![Page 26: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/26.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 26 of 48
Diagnosing diabetes
≥11.1mmol/L7.8 to 11mmol/L**2hr PG <7.8mmol/L
≥7.0mmol/L[5.6] 6.1 to 6.9mmol/L*FPG <6.1mmol/L
DiabetesImpaired fasting glucose*
Impaired glucose tolerance**
Normal
CDA 2003, ADA 2004, WHO 2002
![Page 27: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/27.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 27 of 48
Diagnosis of Diabetes
• Symptoms + gluc >11.0 mmol/l
• 2X FG > 6.9 mmol/l
• 2X 2hr GTT > 11.0 mmol/l
![Page 28: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/28.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 28 of 48
Impaired glucose toleranceImpaired fasting glucose
• Intermediate states
• Increased risk of developing diabetes
• Prevention strategies to prevent or delay progression
• Increased risk of cardiovascular disease
![Page 29: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/29.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 29 of 48
Prevention of type 1 diabetes
Insulin
• Diabetes Prevention Trial
• Diabetes Prediction and Prevention Project
![Page 30: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/30.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 30 of 48
Prevention of type 2 diabetes
Lifestyle modification
• Da Qing Study
• Finnish Diabetes Prevention Study
![Page 31: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/31.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 31 of 48
Prevention of type 2 diabetes
Lifestyle vs medication
• Diabetes Prevention Program
• STOP-NIDDM
![Page 32: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/32.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 32 of 48ACTIVITY
Type 2 diabetes can be delayed in people with IGT
Lifestyle modification is most effective
What do you think could be done at community level to prevent or delay diabetes?
![Page 33: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/33.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 33 of 48
Summary
Type 1 diabetes
• Results from progressive beta-cell destruction
• People with type 1 diabetes need insulin therapy to live
![Page 34: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/34.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 34 of 48
Type 2 diabetes
• Often characterized by insulin insensitivity and relative ratherthan absolute insulin deficiency
• A progressive condition
• Most people with type 2 diabetes will need insulin within 5 to 10 years of diagnosis
Summary
![Page 35: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/35.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 35 of 48
References
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(suppl 1): S5-S10.
2. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diab 2003; 27(suppl 2).
3. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomized trial. Lancet 2002; 346: 393-403.
4. Delahanty LM and Halford BN. The role of Diet Behaviours in Achieving improved glycaemiccontrol in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care 1993; 16(11): 1453-58.
5. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin dependent diabetes mellitus: Diabetes Control and Complications Trial. The Journal of Paediatrics 1994; 125(2): 177-88.
6. Diabetes Control and Complications Trial/epidemiology of diabetes interventions and complications research group intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. New Engl J Med 2003; 348: 2294-303.
7. Diabetes Control and Complications Trial: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
![Page 36: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/36.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 36 of 48
References
8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 297: 356-59.
9. Diabetes Atlas 2006. Brussels: International Diabetes Federation, 2006.
10. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated withthe metabolic syndrome. Diabetes Care 2001; 24(4): 683-9.
11. Pan X, Li G, Hu Y, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4): 537-44.
12. Report of a WHO Consultation. Laboratory Diagnosis and monitoring of Diabetes Mellitus. World Health Organisation 2002. http://whqlibdoc.who.int/hq/2002/9241590483.pdf cited April 30, 2005.
13. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 2001; 344: 1343-50.
14. The Diabetes Prevention Program Research Group. The diabetes prevention Program (DPP). Diabetes Care 2002; 23(12): 2165-71.
15. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulpfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-53.
![Page 37: Diagnosis classification and prevention of diabetes · Slides current until 2008 Diagnosis and types Curriculum Module II-1 Slide 35 of 48 References 1. American Diabetes Association.](https://reader034.fdocuments.net/reader034/viewer/2022042211/5eb1546a12d631282a348986/html5/thumbnails/37.jpg)
Slides current until 2008
Diagnosis and typesCurriculum Module II-1
Slide 37 of 48
References
16. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38. BMJ1998; 317: 703-13.
17. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
18. Harris SB, Ekoe JM, Zdanowicz Y, Webster-Bogaert S. Glycemic Control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diab Research and Clin Pract 2005; 70: 90-7.